Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2641747-54-6
2. Chembl5314463
3. Schembl25240538
4. Gtpl12393
5. Glxc-26887
6. Ex-a8314
7. Da-53430
8. Hy-152848
9. Cs-0641191
10. Structure Z25-2 [wo2021083167a1]
11. (4ar,8m)-11-chloro-10-(2-fluoro-6-hydroxyphenyl)-6-methyl-8-[2-(propan-2-yl)-4-methylpyridin-3-yl]-3-prop2-enoyl-2,3,4,4a,6,8-hexahydro-1hpyrazino[1',2':4,5]pyrazino[2,3-c][1,8]naphthyridine-5,7-dione
| Molecular Weight | 617.1 g/mol |
|---|---|
| Molecular Formula | C32H30ClFN6O4 |
| XLogP3 | 3.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 110 |
| Heavy Atom Count | 44 |
| Formal Charge | 0 |
| Complexity | 1220 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
52
PharmaCompass offers a list of Fulzerasib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fulzerasib manufacturer or Fulzerasib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fulzerasib manufacturer or Fulzerasib supplier.
PharmaCompass also assists you with knowing the Fulzerasib API Price utilized in the formulation of products. Fulzerasib API Price is not always fixed or binding as the Fulzerasib Price is obtained through a variety of data sources. The Fulzerasib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Fulzerasib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fulzerasib, including repackagers and relabelers. The FDA regulates Fulzerasib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fulzerasib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Fulzerasib supplier is an individual or a company that provides Fulzerasib active pharmaceutical ingredient (API) or Fulzerasib finished formulations upon request. The Fulzerasib suppliers may include Fulzerasib API manufacturers, exporters, distributors and traders.
Fulzerasib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fulzerasib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fulzerasib GMP manufacturer or Fulzerasib GMP API supplier for your needs.
A Fulzerasib CoA (Certificate of Analysis) is a formal document that attests to Fulzerasib's compliance with Fulzerasib specifications and serves as a tool for batch-level quality control.
Fulzerasib CoA mostly includes findings from lab analyses of a specific batch. For each Fulzerasib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fulzerasib may be tested according to a variety of international standards, such as European Pharmacopoeia (Fulzerasib EP), Fulzerasib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fulzerasib USP).
